PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 102 filers reported holding PULMONX CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,388,000 | +14.1% | 1,223,754 | +0.8% | 0.28% | +14.1% |
| Q2 2022 | $17,873,000 | -32.9% | 1,214,204 | +13.1% | 0.25% | -16.7% |
| Q1 2022 | $26,644,000 | -33.8% | 1,073,904 | -14.4% | 0.30% | -16.2% |
| Q4 2021 | $40,251,000 | -12.1% | 1,255,100 | -1.4% | 0.36% | -10.8% |
| Q3 2021 | $45,796,000 | +59.4% | 1,272,830 | +95.5% | 0.40% | +70.2% |
| Q2 2021 | $28,727,000 | +78.4% | 651,110 | +85.0% | 0.24% | +70.3% |
| Q1 2021 | $16,100,000 | -27.4% | 352,000 | +9.5% | 0.14% | -23.3% |
| Q4 2020 | $22,183,000 | – | 321,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |